1. 711PHepatocellular carcinoma and liver metastasis treated by hafnium oxide nanoparticles activated by stereotactic body radiation therapy. (23rd October 2018) Authors: Pracht, M; Chajon, E; de Baere, T; Nguyen, F; Bronowicki, J-P; Vendrely, V; Baumann, A-S; Croisé-Laurent, V; Rio, E; Rolland, Y; Le Sourd, S; Gustin, P; Perret, C; Mornex, F; Peiffert, D; Merle, P; Deutsch, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A342 POST-TREATMENT LIVER STIFFNESS MEASUREMENTS PREDICT THE DEVELOPMENT OF LIVER-RELATED COMPLICATIONS IN PATIENTS WITH HCV CIRRHOSIS WHO ACHIEVE SVR POST-DAA THERAPY. (1st March 2018) Authors: Nguyen, F; Galanakis, C; Cooper, C; Tsien, C Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 2 Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Eupraxia, A Step Toward A Plasma-Wakefield Based Accelerator With High Beam Quality. (November 2019) Authors: Nghiem, P A P; Alesini, D; Aschikhin, A; Assmann, R W; Audet, T; Beck, A; Chance, A; Chen, M; Chiadroni, E; Cianchi, A; Clarke, J A; Couprie, M E; Croia, M; Cros, B; Dattoli, G; Del Dotto, A; Delerue, N; Dorda, U; Ferran Pousa, A; Ferrario, M Journal: Journal of physics Issue: Volume 1350(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PD-002A phase I/II trial of hafnium oxide nanoparticles activated by radiotherapy in hepatocellular carcinoma and liver metastasis. (20th June 2018) Authors: Chajon, E; Pracht, M; De Baere, T; Nguyen, F; Bronowicki, J; Vendrely, V; Baumann, A; Croisé-Laurent, V; Rio, E; Rolland, Y; Le Sourd, S; Gustin, P; Perret, C; Mornex, F; Peiffert, D; Merle, P; Deutsch, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PD-002A phase I/II trial of hafnium oxide nanoparticles activated by radiotherapy in hepatocellular carcinoma and liver metastasis. (20th June 2018) Authors: Chajon, E; Pracht, M; De Baere, T; Nguyen, F; Bronowicki, J; Vendrely, V; Baumann, A; Croisé-Laurent, V; Rio, E; Rolland, Y; Le Sourd, S; Gustin, P; Perret, C; Mornex, F; Peiffert, D; Merle, P; Deutsch, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SO-006Hafnium oxide nanoparticles activated by SBRT: a new interventional radiation therapy approach for the treatment of unresectable liver cancers. (2nd July 2019) Authors: Baere, T De; Pracht, M; Rolland, Y; Nguyen, F; Bronowicki, J; Vendrely, V; Cunha, A Sa; Baumann, A; Croisé-Laurent, V; Rio, E; Sourd, S Le; Gustin, P; Perret, C; Peiffert, D; Deutsch, E; Chajon, E Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗